ROKIT HEALTHCARE is dedicated to providing bioinks that are optimized for human tissue printing through innovation by the finest biomedical researchers and material engineers. Our ideal bioink formulations satisfy material and biological requirements that mimic cellular components found in tissue-specific microenvironments.
ROKIT now offers newly and uniquely formulated GELMA based bioink INVIVO GEL series. GelMA is gelatin modified with methacryloyl (MA) groups (degree of MA substitution varies). GELMA can be crosslinked with UV light (365㎚) in the presence of a photo-initiator (i.e. Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP)). INVIVO GEL bioink series has two distinctive advantages compared to other commercially available GELMA based bioink products.